1.
Bamedi T, Dadashizadeh G, Sarabandi A, Tabibian S, Shams M, Dorgalaleh A. Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders. J Cell Mol Anesth [Internet]. 2017 Jan. 1 [cited 2024 May 2];2(1):19-23. Available from: https://journals.sbmu.ac.ir/jcma/article/view/14481